Jonathan Rubin - 27 Dec 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
SVP, Chief Medical Officer
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
27 Dec 2024
Net transactions value
-$39,220
Form type
4
Filing time
30 Dec 2024, 16:13:12 UTC
Previous filing
26 Dec 2024
Next filing
29 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $0 +750 +15% $0.000000 5,822 27 Dec 2024 Direct F1, F2
transaction SUPN Common Stock Tax liability $10,001 -281 -4.8% $35.59 5,541 27 Dec 2024 Direct F3
transaction SUPN Common Stock Options Exercise $0 +1,875 +34% $0.000000 7,416 27 Dec 2024 Direct F4
transaction SUPN Common Stock Tax liability $29,219 -821 -11% $35.59 6,595 27 Dec 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Options Exercise $0 -750 -100% $0.000000 0 27 Dec 2024 Common Stock 750 $0.000000 Direct F5
transaction SUPN Performance Share Unit Options Exercise $0 -1,875 -100% $0.000000 0 27 Dec 2024 Common Stock 1,875 $0.000000 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023.
F2 Includes an aggregate of 431 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F3 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
F4 Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024.
F5 On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024.
F6 On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.